Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (331)	12/12/1998 10:08:00 AM
From: Don Walster	Read Replies (1) \| Respond to of 1386

Hi Yosi s! I bought Pharmos when it was 3 and Omer Shvili was raving about how great it was in Globes. These aren't his words but they are the equivalent of, that it was the greatest thing that had ever come down the pike, the opportunity of a life time. Initially, there was no warning of the amount of time it would take for this gold mine to be uncovered or about the risks involved. I went for the hype, took the bait and bought 60,000 shares which I deeply regret. I do not fault Omer for his enthusiasm. He is a great guy with whom I have corresponded by email. I'm sure he was sincere, and he may well turn out to be right. But in the meantime, the stagnation of Pharmos is adversely effecting the value of his portfolio in Globes. Recently Pharmos was trading on big volume, as I recall it was once close to a million shares, today it is nothing. Why the sudden lack of interest? David Israel-Rosen suggested several times that the fundamental problem was with management, especially their Investor and Public Relations. It is my impression that for this he was soundly spanked, so much so that I haven't seen anything since from him on SI. Now two supporting opinions have been expressed by you, the most recent of which is when you say, "It will take a lot of show me before management gains credibility" for which I hope you are not criticized. I heartily agree with both you and David Israel Rosen and will gladly suffer the consequences. An example of this concern about IR and PR was expressed on SI in the following post: From: Dr. John M. de Castro Thursday, Dec 10 1998 5:01PM ET Reply # of 331 "Why is PARS not not presenting at the H&Q Healthcare Conference? There is no conference that I know of that can move a stock more than the annual Hambrecht & Quist Healthcare Conference. I just got the schedule for the Jan. 10 to Jan. 14 conference. There are around 230 companies presenting. PARS is not one of them. Can anyone explain why? I thought that their new PR firm was going to get them exposure. Well, this is the premiere place to get exposure and they're not there." Some have tried to minimized the importance of this great opportunity for exposure. Some have also defended management, claiming that they are doing superior job. We also have the problem of adequate funds. We know that Pharmos has had to cut back on Research and Development because of lack of funds. A questionable excuse was offered that they had other ways of solving the problem. This is your comment that has to do with funding: "The Only thing that can Help the stock is Sales of Alrex and Lotemax. Here we are hindered by lack of progress: 1. Alrex not being actively promoted to Alergists. ( If you argued that the season was over, well the weather was quite warm and the season exceptionally longer. Yet that segment of the market over 25% is neglected. Same goes for introduction into Europe and other markets. Also Letobra should help. Yet here again there were numerous changes of strategies of how to proceed." Yosi s, I don't understand a lot of the highly technical mumbo jumbo that is posted about Pharmos, but what you are saying is quite clear. It is the kind of information in which investors are vitally interested. In addition to the atrocious IR and PR and the lack of funds, the other thing that concerns me is the length of time all this is going to take. Estimates seem to range from 2 to 5 years. I am under the impression that a lot of changes can occur that could radically change the picture and adversely effect Pharmos. Some have said that if everything else blows up Pharmos will still have Alrex and Lotemax as a source of income. This is small comfort. So, Im stuck with 60,000 shares at 3 and because of low volume, little chance of getting out. I can unload about 10,000 shares at a time, take the loss, and put the money into something less risky. If I sold the 60,000 shares I would suffer a loss of about $90,000. Lest anyone feel sorry for me please don't. I'm a big boy, responsible for my own mistakes for which I blame no once but myself. Also, if I lose the 90 grand it will not effect my standard of living or financial security. So much for what I have intended to share with my many friends on SI for whom I have the greatest respect and admiration in spite of occasional differences. For the record, I intend to hang onto Parmos for a little while in the hope that it will at least get back to 3 and I can get my money back and let it go at that. Kindest regards to Yosi s and all of my other friends, Don Walster

To: yosi s who wrote (331)	12/13/1998 8:58:00 PM
From: arnie h	Read Replies (1) \| Respond to of 1386

Yosi: It's not clear to me why a partner would wait until the 3rd cohort is completed if,in fact, Phamos is negotiating with more than one company. In that event, the only company whose best interest would be served by a delay is Pharmos; although a possible exception is that a deal has been struck but the final terms depend on the results of that cohort. If instead, Pharmos has had a couple of minor offers or some phone calls by low level people, and this has been called negotiating, then delay until the cohort is completed is a necessity. The kind of PR Pharmos has put out as well as reports on this thread would indicate that real negotiations are current with several outfits. I'm more optimistic than the current tone on the thread but negotiating deals is quite a bit more complex than many posters on this thread recognise. Arnie